Sample expansion studies for covid-19 test
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH21C0003
- Awardee
-
Biofire Defense LLC UEI NHMDGM122546
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,973,014
Award facts
- Opportunity
-
- Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization Pre-Solicitation · W81XWH20R0104 · Posted Aug 3, 2020
- Justification and Approval: Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization Limited / Sole Source Justification · Posted Oct 28, 2020
- Notice of Intent: Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization Special Notice · Posted Aug 17, 2020
- Contract value 100% obligated
- $1,973,013.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Millcreek, UT 84107, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$694,766 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $8,000 | |
| Supplemental Agreement for work within scope | $274,060 | |
| Supplemental Agreement for work within scope | -$274,060 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $739,721 | |
| Supplemental Agreement for work within scope | $992,846 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $520,411 | |
| Other Administrative Action | $0 | |
| Original award | $406,802 |
Show all 14
About this award
This is a sole source, cost-plus-fixed-fee contract awarded by the U.S. Army Medical Research Acquisition Activity (USAMRAA) to BioFire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract, valued at $1,973,013.72, is for sample type expansion studies for BioFire Defense's COVID-19 test under Emergency Use Authorization. The objective is to increase the utility of the BioFire COVID-19 test system by studying anterior nares swab and saliva sample types. There is no set-aside designation for this contract. BioFire Defense is the only organization with the regulatory standing to submit an amendment to the existing Emergency Use Authorization for the COVID-19 test, which is used across approximately 1,000 FilmArray instruments deployed by the Department of Defense worldwide.
Quick answers
Who was awarded contract W81XWH21C0003?
W81XWH21C0003 was awarded to Biofire Defense LLC by Defense Health Agency (Department of Defense) on October 15, 2020.
How much is contract W81XWH21C0003 worth?
The government has obligated $1,973,014 on W81XWH21C0003.
Was contract W81XWH21C0003 competed?
The extent of competition for W81XWH21C0003 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award